82 related articles for article (PubMed ID: 9207350)
1. A humanized antibody against human cytomegalovirus (CMV) gpUL75 (gH) for prophylaxis or treatment of CMV infections.
Hamilton AA; Manuel DM; Grundy JE; Turner AJ; King SI; Adair JR; White P; Carr FJ; Harris WJ
J Infect Dis; 1997 Jul; 176(1):59-68. PubMed ID: 9207350
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
[TBL] [Abstract][Full Text] [Related]
3. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
Wang Z; La Rosa C; Maas R; Ly H; Brewer J; Mekhoubad S; Daftarian P; Longmate J; Britt WJ; Diamond DJ
J Virol; 2004 Apr; 78(8):3965-76. PubMed ID: 15047812
[TBL] [Abstract][Full Text] [Related]
4. Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.
Cui X; Freed DC; Wang D; Qiu P; Li F; Fu TM; Kauvar LM; McVoy MA
J Virol; 2017 Jul; 91(13):. PubMed ID: 28381568
[TBL] [Abstract][Full Text] [Related]
5. Non-germ-line encoded residues are critical for effective antibody recognition of a poorly immunogenic neutralization epitope on glycoprotein B of human cytomegalovirus.
Lantto J; Lindroth Y; Ohlin M
Eur J Immunol; 2002 Jun; 32(6):1659-69. PubMed ID: 12115649
[TBL] [Abstract][Full Text] [Related]
6. Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response.
Urban M; Klein M; Britt WJ; Hassfurther E; Mach M
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1537-47. PubMed ID: 8757997
[TBL] [Abstract][Full Text] [Related]
7. Reinfection of cytomegalovirus in renal transplantation.
Ishibashi K; Yamaguchi O; Suzutani T
Fukushima J Med Sci; 2011; 57(1):1-10. PubMed ID: 21701077
[TBL] [Abstract][Full Text] [Related]
8. Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109.
Fouts AE; Comps-Agrar L; Stengel KF; Ellerman D; Schoeffler AJ; Warming S; Eaton DL; Feierbach B
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8209-14. PubMed ID: 24843144
[TBL] [Abstract][Full Text] [Related]
9. Constitutive expression of human cytomegalovirus (HCMV) glycoprotein gpUL75 (gH) in astrocytoma cells: a study of the specific humoral immune response.
Reschke M; Revello MG; Percivalle E; Radsak K; Landini MP
Viral Immunol; 1999; 12(3):249-62. PubMed ID: 10532653
[TBL] [Abstract][Full Text] [Related]
10. Neutralising human recombinant antibodies to human cytomegalovirus glycoproteins gB and gH.
Nejatollahi F; Hodgetts SJ; Vallely PJ; Burnie JP
FEMS Immunol Med Microbiol; 2002 Nov; 34(3):237-44. PubMed ID: 12423777
[TBL] [Abstract][Full Text] [Related]
11. New monoclonal antibodies to the Ebola virus glycoprotein: Identification and analysis of the amino acid sequence of the variable domains.
Panina AA; Aliev TK; Shemchukova OB; Dement'yeva IG; Varlamov NE; Pozdnyakova LP; Bokov MN; Dolgikh DA; Sveshnikov PG; Kirpichnikov MP
Dokl Biochem Biophys; 2016 Mar; 467(1):117-20. PubMed ID: 27193713
[TBL] [Abstract][Full Text] [Related]
12. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.
Boppana SB; Rivera LB; Fowler KB; Mach M; Britt WJ
N Engl J Med; 2001 May; 344(18):1366-71. PubMed ID: 11333993
[TBL] [Abstract][Full Text] [Related]
13. Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors.
Ishibashi K; Tokumoto T; Shirakawa H; Hashimoto K; Ikuta K; Kushida N; Yanagida T; Shishido K; Aikawa K; Toma H; Inoue N; Yamaguchi O; Tanabe K; Suzutani T
Transpl Infect Dis; 2011 Jun; 13(3):318-23. PubMed ID: 20804536
[TBL] [Abstract][Full Text] [Related]
14. Human monoclonal antibodies to cytomegalovirus. Characterization and recombinant expression of a glycoprotein-B-specific antibody.
Böldicke T; Haase B; Böcher M; Lindenmaier W
Eur J Biochem; 1995 Dec; 234(2):397-405. PubMed ID: 8536681
[TBL] [Abstract][Full Text] [Related]
15. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
Goncalvez AP; Men R; Wernly C; Purcell RH; Lai CJ
J Virol; 2004 Dec; 78(23):12910-8. PubMed ID: 15542643
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a humanized antibody with specificity for preS2 surface antigen of hepatitis B virus.
Park SS; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
Hybridoma; 1996 Dec; 15(6):435-41. PubMed ID: 8985755
[TBL] [Abstract][Full Text] [Related]
17. Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein.
Gardner TJ; Stein KR; Duty JA; Schwarz TM; Noriega VM; Kraus T; Moran TM; Tortorella D
Nat Commun; 2016 Dec; 7():13627. PubMed ID: 27966523
[TBL] [Abstract][Full Text] [Related]
18. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates.
Rasmussen L; Geissler A; Cowan C; Chase A; Winters M
J Virol; 2002 Nov; 76(21):10841-8. PubMed ID: 12368327
[TBL] [Abstract][Full Text] [Related]
19. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
